ICORG Renewal 2016-2018

 

In Ireland there are 20,000 new cases of cancer and more than 7,500 cancer deaths each year. A quarter of our annual death toll is cancer related. The number of new cases in the system by 2020 will be 107% of the number in 2000. Since 2005, the HRB has invested in the development of a network of cancer clinical trials in 17 hospitals across Ireland. This significant investment was made in the context of the Memorandum of Understanding on Cancer signed in October 1999 by the Minister for Health and Children of Ireland, the Minister for Health, Social Services and Public Safety of Northern Ireland and the Director of the National Cancer Institute (NCI) of the United States Department of Health and Human Services.

The aims of this initiative are:
1.to ensure that a significant proportion of Irish patients have the option to participate in the latest clinical trials and access to the latest therapies
2.to improve quality of care and to establish a coordinated approach to cancer trials on the island. This has put Ireland in a position of strength in terms of having the critical mass and capacity to participate in large scale cancer clinical trials. More than 8,000 patients have already benefited from access to trials here and the HRB is making an ongoing annual investment of approximately

Award Date
01 January 2016
Award Value
€9,195,200
Principal Investigator
Professor Bryan Hennessy
Host Institution
Irish Clinical Oncology Research Group Ltd
Scheme
Irish Clinical Oncology Research Group